152 related articles for article (PubMed ID: 27013087)
1. Iron overload in hereditary tyrosinemia type 1 induces liver injury through the Sp1/Tfr2/hepcidin axis.
Bao WD; Fan Y; Deng YZ; Long LY; Wang JJ; Guan DX; Qian ZY; An P; Feng YY; He ZY; Wang XF; Phillip Koeffler H; Hu R; Wang J; Wang X; Wang F; Li JJ; Xie D
J Hepatol; 2016 Jul; 65(1):137-145. PubMed ID: 27013087
[TBL] [Abstract][Full Text] [Related]
2. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload.
Wallace DF; Summerville L; Crampton EM; Frazer DM; Anderson GJ; Subramaniam VN
Hepatology; 2009 Dec; 50(6):1992-2000. PubMed ID: 19824072
[TBL] [Abstract][Full Text] [Related]
3. Disruption of hemochromatosis protein and transferrin receptor 2 causes iron-induced liver injury in mice.
Delima RD; Chua AC; Tirnitz-Parker JE; Gan EK; Croft KD; Graham RM; Olynyk JK; Trinder D
Hepatology; 2012 Aug; 56(2):585-93. PubMed ID: 22383097
[TBL] [Abstract][Full Text] [Related]
4. Extrahepatic deficiency of transferrin receptor 2 is associated with increased erythropoiesis independent of iron overload.
Wortham AM; Goldman DC; Chen J; Fleming WH; Zhang AS; Enns CA
J Biol Chem; 2020 Mar; 295(12):3906-3917. PubMed ID: 32054685
[TBL] [Abstract][Full Text] [Related]
5. An engineered Escherichia coli Nissle strain prevents lethal liver injury in a mouse model of tyrosinemia type 1.
Gu P; Xie L; Chen T; Yang Q; Zhang X; Liu R; Guo J; Wei R; Li D; Jiang Y; Chen Y; Gong W; Chen P
J Hepatol; 2024 Mar; 80(3):454-466. PubMed ID: 37952766
[TBL] [Abstract][Full Text] [Related]
6. First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin.
Wallace DF; Summerville L; Lusby PE; Subramaniam VN
Gut; 2005 Jul; 54(7):980-6. PubMed ID: 15951546
[TBL] [Abstract][Full Text] [Related]
7. Hepcidin knockout mice fed with iron-rich diet develop chronic liver injury and liver fibrosis due to lysosomal iron overload.
Lunova M; Goehring C; Kuscuoglu D; Mueller K; Chen Y; Walther P; Deschemin JC; Vaulont S; Haybaeck J; Lackner C; Trautwein C; Strnad P
J Hepatol; 2014 Sep; 61(3):633-41. PubMed ID: 24816174
[TBL] [Abstract][Full Text] [Related]
8. Hepatic stress in hereditary tyrosinemia type 1 (HT1) activates the AKT survival pathway in the fah-/- knockout mice model.
Orejuela D; Jorquera R; Bergeron A; Finegold MJ; Tanguay RM
J Hepatol; 2008 Feb; 48(2):308-17. PubMed ID: 18093685
[TBL] [Abstract][Full Text] [Related]
9. Targeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overload.
Wallace DF; Summerville L; Subramaniam VN
Gastroenterology; 2007 Jan; 132(1):301-10. PubMed ID: 17241880
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 3 Tfr2-deficient murine models suggests distinct functions for Tfr2-alpha and Tfr2-beta isoforms in different tissues.
Roetto A; Di Cunto F; Pellegrino RM; Hirsch E; Azzolino O; Bondi A; Defilippi I; Carturan S; Miniscalco B; Riondato F; Cilloni D; Silengo L; Altruda F; Camaschella C; Saglio G
Blood; 2010 Apr; 115(16):3382-9. PubMed ID: 20179178
[TBL] [Abstract][Full Text] [Related]
11. Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis.
Gleeson F; Ryan E; Barrett S; Russell J; Crowe J
Blood Cells Mol Dis; 2007; 38(1):37-44. PubMed ID: 17098454
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of dichloroacetate treatment in a murine model of hereditary tyrosinemia type 1.
Langlois C; Jorquera R; Finegold M; Shroads AL; Stacpoole PW; Tanguay RM
Biochem Pharmacol; 2006 May; 71(11):1648-61. PubMed ID: 16581029
[TBL] [Abstract][Full Text] [Related]
13. Hereditary Tyrosinemia Type 1 Mice under Continuous Nitisinone Treatment Display Remnants of an Uncorrected Liver Disease Phenotype.
Neuckermans J; Lequeue S; Claes P; Heymans A; Hughes JH; Colemonts-Vroninks H; Marcélis L; Casimir G; Goyens P; Martens GA; Gallagher JA; Vanhaecke T; Bou-Gharios G; De Kock J
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980965
[TBL] [Abstract][Full Text] [Related]
14. CD81 promotes both the degradation of transferrin receptor 2 (TfR2) and the Tfr2-mediated maintenance of hepcidin expression.
Chen J; Enns CA
J Biol Chem; 2015 Mar; 290(12):7841-50. PubMed ID: 25635054
[TBL] [Abstract][Full Text] [Related]
15. A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis.
Gutschow P; Schmidt PJ; Han H; Ostland V; Bartnikas TB; Pettiglio MA; Herrera C; Butler JS; Nemeth E; Ganz T; Fleming MD; Westerman M
Haematologica; 2015 Feb; 100(2):167-77. PubMed ID: 25425686
[TBL] [Abstract][Full Text] [Related]
16. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis.
Fleming RE; Migas MC; Holden CC; Waheed A; Britton RS; Tomatsu S; Bacon BR; Sly WS
Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2214-9. PubMed ID: 10681454
[TBL] [Abstract][Full Text] [Related]
17. Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3.
Drake SF; Morgan EH; Herbison CE; Delima R; Graham RM; Chua AC; Leedman PJ; Fleming RE; Bacon BR; Olynyk JK; Trinder D
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G323-8. PubMed ID: 16935854
[TBL] [Abstract][Full Text] [Related]
18. CHOP-mediated hepcidin suppression modulates hepatic iron load.
Mueller K; Sunami Y; Stuetzle M; Guldiken N; Kucukoglu O; Mueller S; Kulaksiz H; Schwarz P; Strnad P
J Pathol; 2013 Dec; 231(4):532-42. PubMed ID: 23749468
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein-binding endothelial regulator of liver sinusoidal endothelial cells induces iron overload in a fatty liver mouse model.
Hasebe T; Tanaka H; Sawada K; Nakajima S; Ohtake T; Fujiya M; Kohgo Y
J Gastroenterol; 2017 Mar; 52(3):341-351. PubMed ID: 27364348
[TBL] [Abstract][Full Text] [Related]
20. Renal proximal tubular cells acquire resistance to cell death stimuli in mice with hereditary tyrosinemia type 1.
Luijerink MC; van Beurden EA; Malingré HE; Jacobs SM; Grompe M; Klomp LW; Berger R; van den Berg IE
Kidney Int; 2004 Sep; 66(3):990-1000. PubMed ID: 15327392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
